Benlysta (belimumab) - GSK
Saphnelo (anifrolumab-fnia) - AstraZeneca
Clinical Phenotypes, Disease Activity Outcomes, and Glucocorticoid Use Among Belimumab- and Anifrolumab-Treated Patients With Non-Renal SLE (ACR Convergence 2026) - Sep 8, 2026 - Abstract #2238; Pres time: Nov 10, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available 
Clinical • Inflammatory Arthritis
https://eppro02.ativ.me/web/page.php?nav=false&page=Session&project=ACR26&id=3570752
 
Sawyer May, BA
 
Sep 8, 2026
 
Prev Next